Exact Sciences Corp
F:EXK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exact Sciences Corp
F:EXK
|
US |
|
M
|
Monster Beverage Corp
F:MOB
|
US |
|
C
|
Chugai Pharmaceutical Co Ltd
XMUN:CUP
|
JP |
|
I
|
International Petroleum Corp
TSX:IPCO
|
CA |
Intrinsic Value
Is EXK undervalued or overvalued?
See the intrinsic value estimate for Exact Sciences Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
EXK looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with EXK’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Exact Sciences Does
Exact Sciences makes cancer screening and diagnostic tests that help doctors find cancer earlier and choose treatment. Its best-known product is Cologuard, a noninvasive stool test for colon cancer screening. It also sells tumor testing used after a cancer diagnosis, such as Oncotype DX, which helps doctors understand how aggressive a tumor is and whether certain treatments are likely to help.
- Headquarters
- United States of America US
- Employees
- 6 420
- IPO date
- Jan 30, 2001
Revenue & Expenses Breakdown
Exact Sciences Corp
Earnings Waterfall
Exact Sciences Corp
The intrinsic value for Exact Sciences Corp (EXK) under the Base Case is hidden EUR.
Compared with the current market price of 89.28 EUR, the stock appears hidden.